SIRT1 and metabolic dysfunction-associated steatotic liver disease: As examples, the action of the most studied senolytics can be considered; thus, resveratrol has been shown to help prevent non-alcoholic fatty liver disease (NAFLD) by regulating lipid levels and activating the AMPK/SIRT1 axis.